| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 2 | -34,826 | 100% | $1.83 | -$63,778 |
| Net | -2 | -34,826 | -100% | -$63,778 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Patrick J. Heron | Director | $16,249,818 | 23 Jun 2025 | ||
| David A. Socks | CFO & Chief Business Officer | $11,920,353 | 28 Apr 2022 | ||
| Astrid Borkowski | Chief Medical Officer | $3,208,660 | 08 Feb 2024 | ||
| Susan Silbermann | Director | $651,388 | 19 Aug 2022 | ||
| Sean McLoughlin | Chief Operating Officer | $21,225 | 28 Mar 2024 | ||
| TAKEDA PHARMACEUTICAL CO LTD | 10%+ Owner | $0 | 17 Sep 2025 | ||
| JERYL L. HILLEMAN | Director | $0 | 17 Sep 2025 | ||
| Jaime Sepulveda | Director | $0 | 17 Sep 2025 | ||
| Shelley Chu | Director | $0 | 17 Sep 2025 | ||
| Aditya Kohli | Director | $0 | 17 Sep 2025 | ||
| Julie L. Gerberding | Director | $0 | 17 Sep 2025 | ||
| Gary Dubin | Director | $0 | 17 Sep 2025 | ||
| ROBERT HERSHBERG | President and CEO, Director | $0 | -$48,661 | -100% | 17 Sep 2025 |
| L.P. Frazier Life Sciences X | 10%+ Owner | $0 | 17 Sep 2025 | ||
| Shane Maltbie | Chief Financial Officer | $0 | -$15,117 | -100% | 17 Sep 2025 |
| Nanette Cocero | Director | $0 | 17 Sep 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|